Showing 3241-3250 of 23168 results for "".
Thrombocytopenia During Pregnancy
https://reachmd.com/programs/clinicians-roundtable/thrombocytopenia-during-pregnancy/969/A low platelet count during pregnancy can be the result of a disease of pregnancy or an unrelated condition. Your patient’s life depends on you knowing the difference. Learn the answers with Dr. Robert Silver, Professor of Obstetrics and Gynecology at the University of Utah Medical Center and ChiefComprehensive Biomarker Testing in mBC Informs Clinical Decision Making
https://reachmd.com/programs/cme/Comprehensive-Biomarker-Testing-in-mBC-Informs-Clinical-Decision-Making/37332/Join Drs. Jhaveri and Kalinsky and get up to speed on the latest data on PI3K-directed therapies and their role in the treatment paradigm for HR+, HER2- mBC.PI3K Pathway Inhibitors: Safety and Tolerability Profiles
https://reachmd.com/programs/cme/PI3K-Pathway-Inhibitors-Safety-and-Tolerability-Profiles/37338/Join Drs. Jhaveri and Kalinsky and get up to speed on the latest data on PI3K-directed therapies and their role in the treatment paradigm for HR+, HER2- mBC.The Future of PI3K Inhibition in HR+/HER2- Breast Cancer
https://reachmd.com/programs/cme/The-Future-of-PI3K-Inhibition-in-HR-HER2-Breast-Cancer/37339/Join Drs. Jhaveri and Kalinsky and get up to speed on the latest data on PI3K-directed therapies and their role in the treatment paradigm for HR+, HER2- mBC.Triple Threat: Key Data on Simultaneous Estrogen, CDK4/6, and PI3K Inhibition in mBC
https://reachmd.com/programs/cme/Triple-Threat-Key-Data-on-Simultaneous-Estrogen-CDK4-6-and-PI3K-Inhibition-in-mBC/37335/Join Drs. Jhaveri and Kalinsky and get up to speed on the latest data on PI3K-directed therapies and their role in the treatment paradigm for HR+, HER2- mBC.Double Take: Pivotal Data Evaluating PI3K Inhibitor/Endocrine Therapy Regimens in mBC
https://reachmd.com/programs/cme/Double-Take-Pivotal-Data-Evaluating-PI3K-Inhibitor-Endocrine-Therapy-Regimens-in-mBC/37333/Join Drs. Jhaveri and Kalinsky and get up to speed on the latest data on PI3K-directed therapies and their role in the treatment paradigm for HR+, HER2- mBC.Understanding Endocrine Resistance in HR+/HER2- mBC
https://reachmd.com/programs/cme/Understanding-Endocrine-Resistance-in-HR-HER2-mBC/37323/Join Drs. Jhaveri and Kalinsky and get up to speed on the latest data on PI3K-directed therapies and their role in the treatment paradigm for HR+, HER2- mBC.PI3K Pathway Inhibition in HR+/HER2- mBC: Mechanistic Insights
https://reachmd.com/programs/cme/PI3K-Pathway-inhibition-in-HR-HER2-mBC-Mechanistic-Insights/37329/Join Drs. Jhaveri and Kalinsky and get up to speed on the latest data on PI3K-directed therapies and their role in the treatment paradigm for HR+, HER2- mBC.Protecting the Vulnerable from COVID-19: A Street Physician’s Perspective
https://reachmd.com/programs/covid-19-frontlines/protecting-the-vulnerable-from-covid-19-a-street-physicians-perspective/11450/Most Americans are staying home to help control the COVID-19 pandemic, but what happens when a home is made up of cardboard boxes on the street?Study Shows Affordable, OTC SkinCare Offers Benefits After Noninvasive Aesthetic Procedures
https://reachmd.com/ma-issues-index/march-april-2026-issue/study-shows-affordable-otc-skincare-offers-benefits-after-noninvasive-aesthetic-procedures/56637/Topical solutions to boost tolerability of in-office treatments